Company Filing History:
Years Active: 2006-2008
Title: Innovations of Jian-Shen Qi
Introduction
Jian-Shen Qi is a notable inventor based in Branchburg, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of serine proteases. With a total of 2 patents to his name, his work has implications for medical research and therapeutic applications.
Latest Patents
Jian-Shen Qi's latest patents include the invention of a novel human cDNA, termed PRSS11-L, which encodes a polypeptide belonging to the S2/HtrA serine protease family. This invention highlights the widespread expression of PRSS11-L mRNA in various tissues throughout the body, as demonstrated by multi-tissue Northern blotting. The full-length PRSS11-L cDNA was successfully cloned, expressed, and purified, showcasing its proteolytic activity using the protein substrate casein. The isolated nucleic acid or polypeptide molecule can be utilized in detection assays, gene therapy, and screening assays. Another patent focuses on the human PRSS11-like S2 serine protease, further emphasizing the potential applications of PRSS11-L in detection methods, gene therapy, and screening.
Career Highlights
Jian-Shen Qi is currently associated with Ortho-McNeil Pharmaceutical Corporation, where he continues to advance his research and innovations. His work has positioned him as a key figure in the development of therapeutic solutions based on serine proteases.
Collaborations
Some of his notable coworkers include Andrew Lawrence Darrow and Cailin Chen, who have collaborated with him on various projects within the pharmaceutical field.
Conclusion
Jian-Shen Qi's contributions to biotechnology through his patents and research at Ortho-McNeil Pharmaceutical Corporation underscore his role as an influential inventor in the field. His work on PRSS11-L and its applications holds promise for future advancements in medical science.